INTRODUCTION: The purpose of this review is to document current patterns of care for the International Federation of Gynecology and Obstetrics (FIGO) stage @entity3846 to @entity5 in a New Zealand @entity5 centre. METHODS: This is a retrospective review of @entity1 with newly diagnosed FIGO Stage @entity3846 - @entity5 in the Auckland/Northland regions between 2003 and 2007. RESULTS: Two hundred seven @entity1 were identified. Fifty-three percent were stage IB, 24% stage II, 19% stage III and 3% stage @entity3480 . Factors associated with stage >=  IIB were age >50, lack of participation in cervical screening and public first specialist assessment. Ninety percent (90/100) of stage @entity3846 @entity1 and 73% (8/11) of stage @entity3847 @entity1 were treated with primary surgery. Thirty-eight percent of surgically treated stage @entity3846 and 100% of surgically treated stage @entity3847 @entity5 had indications for adjuvant radiotherapy. Radiotherapy utilisation rates were: stage IB 49% ( @entity3846 44%, @entity3847 91%); stage II 93%; stage III 90%; and stage @entity3480 71%. Brachytherapy utilisation rate (BTU) for stages IIB to @entity3480 was 64% overall and 75% in definitively treated @entity1 . Seventy-five percent of @entity1 treated with definitive radiotherapy received concurrent @entity900 chemotherapy. CONCLUSION: Both radiotherapy and brachytherapy utilization rates were below optimal and are being addressed. No formal surgical or chemotherapy utilisation estimates exist for comparison; however, the use of concurrent @entity900 chemotherapy was similar to other groups. A high rate of adjuvant (chemo)radiotherapy was noted in surgically treated Stage IB @entity1 , suggesting a need for an increased consideration of primary chemoradiotherapy in these @entity1 to avoid the unnecessary toxicity of trimodality therapy. Future outcome analysis is planned.

Patterns of care for cervical XXXX in Auckland, New Zealand, 2003-2007.

@entity1 :: ('9606', 'Species') :: ['women', 'patients'] @entity3480 :: ('MESH:C538167', 'Disease') :: ['IVA'] @entity5 :: ('MESH:D009369', 'Disease') :: ['IVA cervical cancer', 'cancer', 'tumours'] @entity900 :: ('MESH:D002945', 'Chemical') :: ['cisplatin'] @entity3846 :: ('9479', 'Gene') :: ['IB1'] @entity3847 :: ('23542', 'Gene') :: ['IB2']
@entity5 :: (MESH:D009369,Disease) :: ['cancer']
